A carregar...
Antagonism of Na(v) channels and α(1)-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine
Ranolazine is a recently developed drug used for the treatment of patients with chronic stable angina. It is a selective inhibitor of the persistent cardiac Na(+) current (I(Na)), and is known to reduce the Na(+)-dependent Ca(2+) overload that occurs in cardiomyocytes during ischemia. Vascular effec...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674695/ https://ncbi.nlm.nih.gov/pubmed/26655634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17969 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|